Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,707.85 +6.92 0.26%
FTSE 100 6,377.97 +3.76 0.06%
DAX 8,273.20 +43.69 0.53%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Fund Type: ETF
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

29.2200 USD 0.4200 1.46%

As of 20:04:07 ET on 06/18/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 28.8000 High - Low: 29.2511 - 28.8000 Primary Exchange: NYSE Arca
Volume: 16,725 52-Week Range: 21.6100 - 30.4300 Beta vs DZOTR: -

ETF Chart for PBE

No chart data available.
  • PBE:US 29.2200
  • 1D
  • 1M
  • 1Y
28.8000
Interactive PBE Chart

Previous Close

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2013-06-18) 29.2125
Assets (M) (on 2013-05-31) 165.1125
Shares out (M) 5.55
Market Cap (M) 162.17
% Premium 0.03
Average 52-Week % Premium -0.0799
Fund Leveraged N

Dividends for PBE

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for PBE

1-Month -1.72% 1-Year +32.40%
3-Month +13.43% 3-Year +16.79%
Year To Date +27.95% 5-Year +11.27%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 06/18/2013
Name Position Value % of Total
Waters Corp 84,524 8,612,996 5.311%
Illumina Inc 116,245 8,333,604 5.139%
Amgen Inc 81,312 8,253,168 5.089%
Regeneron Pharmaceuticals Inc 33,796 8,204,317 5.059%
Life Technologies Corp 110,315 8,193,095 5.052%
Sigma-Aldrich Corp 97,709 8,029,726 4.951%
Gilead Sciences Inc 150,043 7,793,233 4.806%
Biogen Idec Inc 34,420 7,255,736 4.474%
Luminex Corp 231,382 4,808,118 2.965%
Isis Pharmaceuticals Inc 205,946 4,753,234 2.931%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil